News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
331,432 Results
Type
Article (14180)
Company Profile (150)
Press Release (317102)
Section
Business (99058)
Career Advice (359)
Deals (16648)
Drug Delivery (53)
Drug Development (34930)
Employer Resources (64)
FDA (9522)
Job Trends (8192)
News (162863)
Policy (14781)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (4)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1407)
Accelerated approval (1)
Adcomms (8)
Allergies (53)
Alliances (30030)
ALS (46)
Alzheimer's disease (701)
Antibody-drug conjugate (ADC) (70)
Approvals (9574)
Artificial intelligence (182)
Autoimmune disease (10)
Automation (12)
Bankruptcy (86)
Best Places to Work (7300)
BIOSECURE Act (19)
Biosimilars (82)
Biotechnology (98)
Bladder cancer (41)
Brain cancer (16)
Breast cancer (148)
Cancer (1239)
Cardiovascular disease (86)
Career advice (316)
Career pathing (10)
CAR-T (82)
Cell therapy (257)
Cervical cancer (12)
Clinical research (29363)
Collaboration (615)
Compensation (127)
Complete response letters (12)
COVID-19 (1071)
CRISPR (21)
C-suite (150)
Cystic fibrosis (49)
Data (1190)
Denatured (15)
Depression (18)
Diabetes (122)
Diagnostics (3408)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (23)
Drug discovery (69)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (51)
Earnings (33215)
Editorial (7)
Employer branding (6)
Employer resources (56)
Events (50199)
Executive appointments (496)
FDA (10337)
Featured Employer (44)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (527)
Gene editing (54)
Generative AI (15)
Gene therapy (171)
GLP-1 (274)
Government (2212)
Grass and pollen (2)
Guidances (31)
Healthcare (9968)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (55)
Indications (24)
Infectious disease (1144)
Inflammatory bowel disease (89)
Inflation Reduction Act (7)
Influenza (31)
Intellectual property (58)
Interviews (44)
IPO (7233)
IRA (26)
Job creations (1280)
Job search strategy (286)
Kidney cancer (4)
Labor market (9)
Layoffs (145)
Leadership (5)
Legal (2272)
Liver cancer (38)
Lung cancer (183)
Lymphoma (78)
Machine learning (2)
Management (18)
Manufacturing (208)
MASH (19)
Medical device (9174)
Medtech (9177)
Mergers & acquisitions (9809)
Metabolic disorders (261)
Multiple sclerosis (29)
NASH (3)
Neurodegenerative disease (30)
Neuropsychiatric disorders (6)
Neuroscience (943)
NextGen: Class of 2025 (3231)
Non-profit (2438)
Northern California (1215)
Now hiring (12)
Obesity (115)
Opinion (116)
Ovarian cancer (42)
Pain (47)
Pancreatic cancer (44)
Parkinson's disease (71)
Partnered (14)
Patents (125)
Patient recruitment (66)
Peanut (35)
People (30482)
Pharmaceutical (41)
Pharmacy benefit managers (3)
Phase I (8970)
Phase II (12197)
Phase III (10643)
Pipeline (558)
Podcasts (21)
Policy (63)
Postmarket research (945)
Preclinical (3171)
Press Release (69)
Prostate cancer (63)
Psychedelics (8)
Radiopharmaceuticals (185)
Rare diseases (190)
Real estate (3108)
Recruiting (25)
Regulatory (11491)
Reports (22)
Research institute (1384)
Resumes & cover letters (38)
Rett syndrome (1)
RNA editing (1)
RSV (15)
Schizophrenia (36)
Series A (94)
Series B (60)
Service/supplier (10)
Sickle cell disease (27)
Southern California (1171)
Special edition (4)
Spinal muscular atrophy (58)
Sponsored (18)
Startups (2048)
State (1)
Stomach cancer (5)
Supply chain (34)
The Weekly (5)
United States (12595)
Vaccines (313)
Venture capitalists (20)
Webinars (6)
Weight loss (54)
Women's health (20)
Worklife (7)
Date
Today (77)
Last 7 days (379)
Last 30 days (1830)
Last 365 days (21397)
2025 (4823)
2024 (22024)
2023 (23584)
2022 (29469)
2021 (30916)
2020 (29017)
2019 (26277)
2018 (19822)
2017 (17966)
2016 (16708)
2015 (18692)
2014 (13226)
2013 (10523)
2012 (11187)
2011 (11222)
2010 (9420)
Location
Africa (290)
Alabama (29)
Alaska (4)
Arizona (76)
Arkansas (12)
Asia (22282)
Australia (2899)
California (2999)
Canada (1079)
China (402)
Colorado (152)
Connecticut (173)
Delaware (86)
Europe (50030)
Florida (490)
Georgia (123)
Idaho (30)
Illinois (325)
India (16)
Indiana (212)
Iowa (7)
Japan (95)
Kansas (49)
Kentucky (14)
Louisiana (5)
Maine (31)
Maryland (610)
Massachusetts (2293)
Michigan (126)
Minnesota (232)
Mississippi (1)
Missouri (65)
Montana (24)
Nebraska (12)
Nevada (37)
New Hampshire (42)
New Jersey (1166)
New Mexico (21)
New York (972)
North Carolina (638)
North Dakota (8)
Northern California (1215)
Ohio (132)
Oklahoma (11)
Oregon (21)
Pennsylvania (705)
Puerto Rico (6)
Rhode Island (22)
South America (434)
South Carolina (16)
South Dakota (1)
Southern California (1171)
Tennessee (67)
Texas (486)
Utah (100)
Virginia (74)
Washington D.C. (36)
Washington State (244)
West Virginia (1)
Wisconsin (47)
331,432 Results for "innovent biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 30, 2025
·
10 min read
Press Releases
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 13, 2025
·
9 min read
Press Releases
ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
January 23, 2025
·
3 min read
Press Releases
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
November 5, 2024
·
5 min read
Press Releases
Theriva™ Biologics to Present at the 2025 NeauxCancer Conference
March 20, 2025
·
2 min read
Press Releases
FairJourney Biologics Establishes Supervisory Board
March 25, 2025
·
4 min read
Deals
Advanced Biologics Elevates Biologic Innovations Through Merger with Isto Biologics.
Advanced Biologics (known commercially as Biologica Technologies), a California-based company known for their innovative biologic solutions, announced today their successful merger with Isto Biologics, a global leader in regenerative and autologous therapies.
October 18, 2023
·
3 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Opinion
Fixing the IRA’s Pill Penalty Is Critical to Supporting Small Molecule Innovation
Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from investing in potentially transformative therapies. Fixing some of the unintended consequences of the IRA will clear the way for innovative medicines to reach patients in need.
February 25, 2025
·
6 min read
·
Thomas M. Kaiser
Diabetes
Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval
Innovent Biologics’ dual GLP-1/glucagon receptor agonist mazdutide is also being developed for chronic weight management. China’s regulator accepted Innovent’s drug application for this indication in February 2024.
July 22, 2024
·
2 min read
·
Tristan Manalac
1 of 33,144
Next
